Has Benton Emblom, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,986,387 in general payments to Benton Emblom, MD across 175 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Benton Emblom, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Benton Emblom, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Benton Emblom, MD

Orthopaedic Surgery · Birmingham, ALNPI 1588873350

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,882,709 of the $2,986,387 with a category attached, or 96.5%. Arthrex accounts for 99.9% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $856,696, more than ten times the $59,311 reported in 2019. Among orthopaedic surgery clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,986,387in general payments, 2019–2025

Across 175 payments — averaging $17,065 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Arthrex$3M
Prime Surgical, LLC$999
Zimmer Biomet$904
Stryker$772
Pacira Therapeutics, Inc.$258
Orthalign Inc$185
plus $309 from 6 others

$118,975in research payments, 2019–2025

Across 9 payments — averaging $13,219 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Arthrex$119K

What the payments were for

Royalty or licence$2,882,70997%
Consulting fees$44,3001%
Speaking & faculty fees$51,2082%
Travel & lodging$2,7490%
Food & beverage$5,4210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Arthrex	138	$2,982,961
Prime Surgical, LLC	10	$999
Zimmer Biomet	9	$904
Stryker	7	$772
Pacira Therapeutics, Inc.	2	$258
Orthalign Inc	2	$185
DJO, LLC	1	$149
Johnson & Johnson	2	$81
Conmed Corporation	1	$23
Molnlycke Health Care US, LLC	1	$23
Convatec Inc.	1	$19
Daiichi Sankyo Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARTHREX$12,433,889
SHOULDER IMPLANTS FIBERTAK KNOTLESS$192,635
SHOULDER IMPLANTS BICEPS REPAIR SWIVELOCK TENODESIS$188,502
KNEE & HIP IMPLANTS HIP FIBERTAK$181,314
SHOULDER IMPLANTS ROTATOR CUFF FIBERTAK$137,347
CAPITAL CONSUMABLES CONSUMABLES TUBING OUTFLOW$1,500
KNEE & HIP IMPLANTS MENISCAL REPAIR SOFTSTITCH$1,000
CAPITAL CONSUMABLES CONSUMABLES BLADES & BURRS SU BLADES$1,000
CAPITAL CONSUMABLES CONSUMABLES BLADES & BURRS SPECIALTY$500
INSPACE$373
MAKO$357
AccuFill$274
Zilretta$258
ORTHALIGN PLUS$147
Sports Medicine-None$136
SHOULDER IMPLANTS BICEPS REPAIR FIBERTAK$134
Biowick$125
AIR$114
CROSSFIRE$114

How this compares

$2,986,387 in reported general payments places this provider in the 95th percentile of 319 orthopaedic surgery providers in Alabama.

See all orthopaedic surgery providers in Alabama →

Medicare billing

Part B allowed, 2024

$134,219

Medicare patients

213

Services billed

999

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ondansetron Hcl	172	$1,726
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	162	$1,486
Celecoxib	26	$723
Cyclobenzaprine Hcl	105	$397
Cefadroxil	80	$343
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	42	$300
Diclofenac Sodium	18	$267
Cephalexin	84	$178
Tramadol Hcl	26	$129
Mupirocin	11	$122
Gabapentin	20	$84
Meloxicam	29	$60

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Birmingham

Jeffrey DugasBirmingham$11.5M
Herrick SiegelBirmingham$1.2M
Kenneth MooreBirmingham$342K
Joseph SherrillBirmingham$221K
Jonathan QuadeBirmingham$217K
Ginger BryantBirmingham$209K
Marcus RothermichBirmingham$207K
Daniel KimBirmingham$147K
Eugene BrabstonBirmingham$117K
Michael JohnsonBirmingham$74K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →